chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On April 11 I woke up with severe ringing in my ears and vertigo. The ringing in my ears lasted for 2 weeks. I am still experiencing vertigo, some days are better than others. In the last week it has gotten better.  On the same day as the above event, I started my period. I am peri-menopausal and had not had a period in 3 months.  Since April 11, 2021 I have had spotting or a mild period nearly every day.
Covid symptoms; Initial information received on 03-Jan-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 23 years old female patient who had covid symptoms while receiving vaccine RABIES (HDC) VACCINE [IMOVAX RABIES].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 03-Jan-2021, the patient received a  dose of suspect RABIES (HDC) VACCINE lot number not reported via unknown route in unknown administration site.  On 03-JAN-2022 the patient developed a non-serious covid symptoms (covid-19) 1 year following the administration of RABIES (HDC) VACCINE.  Action taken with was not applicable.  It was not reported if the patient received a corrective treatment for the event (Covid symptoms).  At time of reporting, the outcome was Unknown for the event covid symptoms.
2/6/2021 I woke up and had pressure in my left ear. 2/7/2021 I had extreme pressure, vertigo and headache, kept vomiting through the night and totally lost my hearing. 2/8/2021 went to the doctor and was prescribed prednisone and anti-nausea medication. Within a week I still had balance issues. As of today, I cannot hear in left ear.
Patient received HPV and Varicella vaccine on 10/12/15. Noticed RSQ red/swollen. Stated she received the varicella on the right arm and HPV on the left. Iced site and TYLENOL given 10/13/15.
Info has been received from a mother concerning her 18 month old son who was vaccinated with Hep-B. Concomitant therapy included Haemophilus B conjugate vaccine (+) Hep-B vaccine recombinant (yeast). In approx. June, 2002, the mother reported that her son had not started to speak yet. Additional info has been requested.
vaccine was admnistered after experiencing temperature excursion; no additonal AE; This spontaneous report was received from medical assistant concerning a 12 months old patient. No information about the patient's current condition, medical history or concomitant therapy was reported.       On 29-SEP-2021, medical assistant reported varicella virus vaccine live (oka/merck)(VARIVAX) was administered (dose and route were not reported; lot# T032317, expiry date: 22-SEP-2022) after experiencing temperature excursion as prophylaxis (product storage error). The vaccine was stored at 6 Fahrenheit to 14 Fahrenheit for 18 minutes and 6 Fahrenheit to 14 Fahrenheit (11.9 Fahrenheit) for 1 hour. Total time frame was 1 hour and 18 minutes. No previous temperature excursion was reported. No additional adverse event details were available.
pt was inadvertently given DTP instead of adult TD;w/in 18-24hrs p/vax pt exp an inj site rxn (swelling @ site), fatigue, myalgias & arthralgias;no tx had been initiated @ time of the report;
FULLY VACCINATED, ADMITTED TO HOSPITAL 8/20/2021 POSITIVE COVID-19
Administered after temperature excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a adult male patient who received Herpes zoster (Shingrix) (batch number LG3B4, expiry date 8th April 2023) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 12-Aug-2022 Reporter's comment: The medical assistant stating that refrigerator temperature log indicated out of range temperatures for Shingrix.   The lowest recorded was 3.7 degrees Celsius and the highest was 9.2 degrees Celsius on 7th August 2022 (for 48 minutes).   This case is for 10 out of 10 linked patients reported by same reporter. Additional supportive information: The patient received Shingrix after temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2022118614:Same reporter. US-GSK-US2022118570:Same reporter. US-GSK-US2022118615:Same reporter. US-GSK-US2022118568:Same reporter. US-GSK-US2022118613:Same reporter. US-GSK-US2022118612:Same reporter. US-GSK-US2022118569:Same reporter. US-GSK-US2022118571:Same reporter. US-GSK-US2022118572:Same reporter
1st dose of Pfizer Covid vaccine received on December 2, 2021. 2nd dose of Pfizer Covid vaccine received on December 23, 2021. After 3 weeks of 2nd dose (around January 13, 2022), we (parents) noticed patient's aggressive hair fall. After the 2nd Covid shot, the vaccine triggered his underlying condition (alopecia arreata) and after the immense weekly hair fall, it has caused complete - ABSOLUTE - hair loss and balding within 1.5 months (mid January-February 2022). This had NEVER HAPPENED BEFORE.
Plunger on PREVNAR 13 syringe was depressed before needle was fully inserted so vaccine was probably injected into subcutaneous tissue instead of intramuscularly.
This case was reported by a non-health professional and described the occurrence of influenza-like symptoms in a female patient who received SHINGRIX. Previously administered products included Flu vaccine with an associated reaction of pain in extremity (refer case US2018GSK036920). On an unknown date, the patient received SHINGRIX at an unknown dose. In February 2018, less than a month after receiving SHINGRIX, the patient experienced influenza-like symptoms, fever, pain in arm and feeling bad. On an unknown date, the outcome of the influenza-like symptoms, fever, pain in arm and feeling bad were unknown. It was unknown if the reporter considered the influenza-like symptoms, fever, pain in arm and feeling bad to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not provided. The patient felt pretty bad in the morning with fever and flu-like symptoms. At the time of reporting, the patient was much better although arm was bit sore but no worse than the flu vaccination. The patient was told to get the 2nd dose between 2 and 6 months, was there a sweet spot or anytime in the range would work equally well.
A report has been received from a Pharmacist concerning, subjects of unknown gender, who had been receiving FLUMIST QUARDIVALENT (intranasal). FLUMIST QUARDIVALENT started on an unknown date. It was reported by Pharmacist that seven doses of expired FLUMIST QUARDIVALENT were given to patients. The outcome of the event of administration of expired dose is unknown. The report was considered to be non-serious.
From a telephone call received on 08/13/02, it was reported that a 5 year old patient was vaccinated with Daptacel, IPOL & MMR vaccines (sites and lot numbers not provided) on 08/08/02. On 08/09/02, the patient developed redness, swelling, pain, itching and three nickel size hives at the injection site. Tylenol and Benadryl. These symptoms resolved per reporter. Case linked reports U20002-00633 & U20002-00634. From follow up info received on 11/14/02, it was reported htat the pt had no illnesses or allergies at the time of vaccination. No lab work or diagnostic tests were performed. Pt was not on any other medication at time of vaccination. Physician's info has been updated. No further info has bene provided. The case is closed.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. The patient was vaccinated with RECOMBIVAX HB (lot # 669597/0294AA and expiry date was 06-SEP-2014, route and dose were not reported) that was exposed to 25 Fahrenheit for an unknown period of time on 22-OCT-2012. No concomitant medications were reported. No adverse symptoms reported. This is one of several reports received from the same reporter. Follow up information was received from the licensed practical nurse who confirmed that none of the patients complained of any adverse experiences after receiving the above vaccines that had been stored incorrectly. Additional information is not expected.
1st dose 2017, 2nd not yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a adult female patient who received HAV (Havrix) for prophylaxis.   Previously administered products included Havrix (received the 1st dose of Havrix in 2017).   On an unknown date, the patient did not receive the 2nd dose of Havrix. On an unknown date, unknown after receiving Havrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 10-NOV-2022 Reporter's Comment: The reporter did not have patient's DOB (date of birth) or exact date of vaccination.  The reporter believed that, patient was in her 30's and she stated patient said she received the 1st dose 5 years ago. The patient does not remember if it was the Havrix she received 5 years ago. The reporter reported that a patient would like to get the 2nd dose of Havrix. The reporter consented to follow up via mail. Additional Supportive Information: Till the time of reporting, the patient did not receive the 2nd dose of Havrix, which led to incomplete course of vaccination.
Five days after injection she developed a supraclavicular lymph node on the right side, about 2cm in diameter
At approximately 7:55PM, patient developed near syncopal episode, "I felt like I was going to pass out". Patient became nauseated and shaky. This lasted for approximately 10-15 minutes. For the next several hours the patient was light headed/ dizzy. The patient also felt short of breath, more so with activity.  At around 9PM, the patient took diphenhydramine 50mg x 1 and acetaminophen 1000mg x1. The patient then laid down for the evening and awoke around 10 AM feeling much better.
This was a quadrivalent influenza shot. On Sunday afternoon/evening, about 48h later, she felt poorly. Low appetite, itchy eyes, sore throat, not feeling right. She complained of "fireplace eyes" and said something was wrong with her. Fell asleep at about 8 in a chair, early for her. At 11 PM, I took her temp in armpit, 100.2 and gave her 1.5 tabs ibuprofen to help her fever and headache she said she had. Fever broke. Next day, complained of headache again and again gave ibuprofen. Later in the day she was feeling better. Tuesday, her symptoms have resolved and she is feeling fine.
patient received the Rotarix diluent only; patient received the Rotarix diluent only; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 4-month-old female patient who received Rota (Rotarix lyophilized formulation) (batch number 789CH, expiry date 8th July 2023) for prophylaxis.   Co-suspect products included rotavirus vaccine oral applicator device (Rotarix Oral Applicator Device) oral applicator for prophylaxis.   On 14th November 2022, the patient received Rotarix lyophilized formulation and Rotarix Oral Applicator Device. On 14th November 2022, unknown after receiving Rotarix lyophilized formulation and Rotarix Oral Applicator Device, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 14-NOV-2022 Reporters comment: The nurse reported that infant received the Rotarix diluent only.  The lot number and expiry were for the diluent that was administered. The reporter consent to follow-up. Additional Supportive information: The patient received the Rotarix diluent only, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered
After receiving the injection, patient reported she would not be back for her second dose as she had already received the J&J vaccine several months ago and wanted to get her 'booster'.  I informed her that getting a booster dose after the J&J vaccine has not been approved by any governing bodies.
Two weeks after receiving the vaccine my left shoulder, left thumb and lower back started hurting.  It felt like a flare of arthritis though I've never had arthritis in these areas before.  Pain is only with movement.  At the beginning I would rate the pain as 7 out of 10.   I have only used topical pain control.  My back stopped hurting after about 1 month but my shoulder and thumb still ache.  Pain is now 3 out of 10
apparent tonic bilateral sz approx w/near apneic episode; occurred 1 hr 15 mins p/vax given; lasted-10min & spontaneously resolved; No recurred full recovery;
Immediate diarrhea and nausea 15 minutes after first shot, then headache a few hours later. The diarrhea lasted for 5 days. The nausea and headache went away the day after the shot.
Fever (100.2), malaise, lethargy. Gave ibuprofen for comfort with good effect.
4 hrs after receiving immunizations, PT started running temperature, crying inconsolably then by 8 hrs after vax had 104 R temp and had very red cheeks so was taken to ER for evaluation. Back to normal w/in 24 hrs.
Pt received Moderna Bivalent as second dose.   No TX needed at this time Pt will received a second dose of the bivalent in two months
Patient felt sweaty and nauseous right after shot was given.  Vomited a little.  Patient was given cold compress for neck and after 30 minutes felt fine.  contacted patient 3 hours later and was still feeling fine.
Flu-like symptoms following injection 11/1/99. Worsened 11/13/99 through 11/15/99. Paralysis 11/16/99. Dx with Transverse Myelitis.
Improperly stored vaccine adminstration; shipment was received a day late; This spontaneous report was received from a an administrator via a field representative referring to a 65 years old male patient. Information about concurrent condition, concomitant medication, medical history, drug reactions or allergies was unknown.   On 22-OCT-2020, the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) shipment was received a day late (expected arrival date was 21-OCT-2020, product shipment delay) to the reporter's practice, they were not viable for use, and someone in the office mistakenly placed them in the vaccine fridge (confliction information: the box of vaccines got placed into a refrigerator at recommended storage range once received).   On 27-OCT-2020, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (0.5 ml, lot # T020638, expiration date 26-FEB-2022; route was not reported) for prophylaxis (improper storage of product in use).  This is one of several reports received from the same reporter. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T020638; expirationdate: 26-FEB-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent; Sender's Comments:  US-009507513-2011USA015360: US-009507513-2010USA011251: US-009507513-2011USA015362: US-009507513-2011USA015359: US-009507513-2011USA015363: US-009507513-2011USA015357: US-009507513-2011USA015358:
Patient was monitored for any adverse reactions post booster vaccination. No adverse reactions noted. No fever, no chills, no difficulty breathing. No allergic reactions noted.
Abrupt onset of headache, low grade fever and face pain. Patient evaluated 11/6/08 and diagnosed with sinusitis.
Nocturnal Seizure. Now experiencing generalized clonic tonic seizures.  Needs medication to suppress.
My ENT doctor had a rheumatological incidence after the Moderna booster; This spontaneous case was reported by a consumer and describes the occurrence of RHEUMATIC DISORDER (My ENT doctor had a rheumatological incidence after the Moderna booster) in a  patient of an unknown age and gender who received mRNA-1273 (MODERNA COVID-19 VACCINE, for COVID-19 prophylaxis.  No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273(ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHEUMATIC DISORDER (My ENT doctor had a rheumatological incidence after the Moderna booster). At the time of the report, RHEUMATIC DISORDER (My ENT doctor had a rheumatological incidence after the Moderna booster) outcome was unknown.            The concomitant medication was not reported by reporter. The treatment medication was not reported by reporter.  Company comment: This is a spontaneous case reported by a consumer. A patient of an unknown age and gender received a dose of mRNA-1273  and experienced non serious event of rheumatic disorder. Vaccination date and onset date of the event were not provided, latency cannot be assessed. No further details regarding clinical course, diagnostic tests or treatment performed were disclosed. The benefit-risk relationship of mRNA-1273  vaccine is not affected by this report.      Reporter did not allow further contact; Sender's Comments: This is a spontaneous case reported by a consumer. A patient of an unknown age and gender received a dose of mRNA-1273  and experienced non serious event of rheumatic disorder  Vaccination date and onset date of the event were not provided, latency cannot be assessed. No further details regarding clinical course, diagnostic tests or treatment performed were disclosed.
Prior to receiving the vaccine I was in excellent physical condition - able to run, lift, and exert myself to high capabilities. Shortly after receiving the vaccine I started experiencing chest pains, intense palpitations, and a sharp decline in cardiovascular performance. I could not find a doctor to take my concerns seriously. Fast forward to 11/22 and I was hospitalized with chest pains. I have since then suffered a heart attack and a stroke and am on several heart failure medications.
She had a red, swollen band around her arm (at the bicep). About 4-5 inches wide and wrapped around most of her arm. She saw her doctor and they said it was the start of cellulitis.
Hospitalization for altered mental status/Dementia, pneumonia on dates 7/20/2023- 8/3/2023. Treated with dexamethasone, baricitinib, Remdesivir, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Numbness on the left side of face; Swelling on the left side of face.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the right arm on 18Mar2021 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity and High Blood Pressure (HBP). The patient was allergic to bee, hornets and wasp stings. Concomitant medications included losartan potassium (LOSARTIN), paroxetine hydrochloride (PAROXETINE), hydrochlorothiazide (MANUFACTURER UNKNOWN) and vitamin D (MANUFACTURER UNKNOWN), all taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EM9809) via an unspecified route of administration in the left arm on 25Feb2021 at 15:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021, the patient experienced swelling and numbness on the left side of face. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event swelling and numbness on the left side of face was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
After 10 days i developed rash and allergies on my hands and other ramdon parts of my body
The patient did not have any adverse effects from the vaccine. I consulted the appropriate person and they informed me what next vaccine should be given.
Audible Hallucinations / Delusions Insomnia Anxiety  Fluctuating Blood pressure  Urinary Tract Infection
Pt states noticed severe itching to body on 6/29/2010.  Noticed faint rash on 7/1/2010.
high pitched cont cry for 6hr p/vax;irritable through the following day;observation, compresses, APAP;
Patient felt funny. Onsite EMS was called vitals were taken BP 108/68  98% O2 room air BG 108 HR 72. General Malaise unknown cause patient refused evaluation/care. Left aginst medical advice.
Arm vaccine given swollen and red and hot, had fever 100-102 within hours for 5 days, joints hurt, shakes to point of not able to pick up glass of water, headache, extreme thirst, extreme tiredness and sleepy. I had vaccine on Wed. and had all of these symptoms until I stopped my Lithium Sunday and by Wed. I was feeling better. I drank as much water as I could and restarted my Lithium due to the side effects I had from stopping and I no vaccine issues today 4/9/2021 my issues from medication is starting to settle down. I only stopped the Lithium which is 600mg a day - I take 4 pills that are 150mg each.
patients who are under age 18 and received Flublok; Initial information regarding an unsolicited valid non-serious case received from a other health professional and transmitted to Sanofi on 02-Nov-2020.  This case is linked to cases 2020SA309245, 2020SA309246 and 2020SA309247.  This case involves a 16 years old female patient patients who are under age 18 and received flublok, (Product administered to patient of inappropriate age).  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 05-Oct-2020, the patient received a dose 0.5 ml once of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot QFAA2032 (30-JUN-2021).  The patient who are under age 18 and received flublok (Product administered to patient of inappropriate age).  It was not reported if the patient received a corrective treatment.  The event outcome was reported as Not Applicable.  Sanofi company comment dated 18-Sep-2020: Based on the information provided by the reporter the causal role of company suspect drugs cannot be excluded for the serious unlisted event, considering the plausible temporal relationship. However more information about the medical history and concomitant medications of the patient are required for the proper assessment of the case.